Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics, as well as non-steroidal anti-inflammatory drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Stock data | 2024 | Change |
---|---|---|
Price | $3.05 | N/A |
Market Cap | $280.95M | N/A |
Shares Outstanding | 92.03M | N/A |
Employees | 996.00 | N/A |